Abstract
Ascending pathways mediated by monoamine neurotransmitters regulate the firing mode of thalamocortical neurons and modulate the state of brain activity. We hypothesized that specific neuropeptides might have similar actions. The effects of vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) were tested on thalamocortical neurons using whole-cell patch-clamp techniques applied to visualized neurons in rat brain slices. VIP (2 μm) and PACAP (100 nm) reversibly depolarized thalamocortical neurons (7.8 ± 0.6 mV; n = 16), reduced the membrane resistance by 33 ± 3%, and could convert the firing mode from bursting to tonic. These effects on resting membrane potential and membrane resistance persisted in the presence of TTX. Morphologically diverse thalamocortical neurons located in widespread regions of thalamus were all depolarized by VIP and PACAP38. In voltage-clamp mode, we found that VIP and PACAP38 reversibly activated a hyperpolarization-activated cationic current (IH) in thalamocortical neurons and altered voltage- and time-dependent activation properties of the current. The effects of VIP on membrane conductance were abolished by the hyperpolarization-activated cyclic-nucleotide-gated channel (HCN)-specific antagonist ZD7288, showing that HCN channels are the major target of VIP modulation. The effects of VIP and PACAP38 on HCN channels were mediated by PAC1 receptors and cAMP. The actions of PACAP-related peptides on thalamocortical neurons suggest an additional and novel endogenous neurophysiological pathway that may influence both normal and pathophysiological thalamocortical rhythm generation and have important behavioral effects on sensory processing and sleep–wake cycles.
- vasoactive intestinal polypeptide
- pituitary adenylate cyclase-activating polypeptide
- thalamocortical neurons
- cAMP
- IH
- HCN channels
- depolarization
Introduction
Thalamocortical neurons exhibit two distinct functional states, characterized by tonic and burst firing (Jahnsen and Llinas, 1984a,b), that are associated with different levels of consciousness (for review, see Steriade and McCarley, 1990). Rhythmic and synchronous burst firing occurs during slow-wave sleep and paroxysmal events such as absence seizures. Tonic firing, in contrast, underlies activity during waking and rapid eye movement (REM) sleep and allows for a faithful, linear relay of sensory information to the neocortex. Steady depolarization of thalamocortical neurons causes a transition from burst to tonic firing mode, associated with development of an alert behavioral state (for review, see Steriade and McCarley, 1990; McCormick and Bal, 1997). In the past 10 years, several lines of evidence have suggested that the interaction between ascending neurotransmitter systems and several ion channels, particularly those mediating a leak K+conductance and a hyperpolarization-activated nonselective cation conductance [IH and hyperpolarization-activated cyclic-nucleotide-gated channels (HCN)] (cf. Ludwig et al., 1998; Santoro et al., 2000), are responsible for the transition between firing modes observed in thalamocortical neurons (for review, see McCormick, 1992b; McCormick and Bal, 1997). Monoaminergic nerve fibers originating from the brainstem, hypothalamus, and basal forebrain containing 5-HT, noradrenaline (NA), and histamine form major components of the ascending neurotransmitter system. These neurotransmitters activateIH channels on thalamocortical relay cells (Pape and McCormick, 1989; McCormick and Pape, 1990a,b; McCormick and Williamson, 1991; for review, see McCormick, 1992b) or block leak K+ currents in these neurons (McCormick and Prince, 1988; McCormick, 1992a). However, in addition to these classical neurotransmitters, other endogenous substances such as peptides may affect IH channels and, thus, modulate thalamic excitability and cell firing mode.
Anatomical studies have demonstrated abundant peptidergic projections into mammalian thalamus. Recent evidence suggests that several endogenous neuropeptides, including NPY, somatostatin, and nociceptin/orphanin FQ, activate G-protein-dependent inwardly rectifying K+ channels and hyperpolarize thalamocortical neurons and/or reticular neurons (Sun et al., 2001,2002; Meis et al., 2002), whereas the peptides cholecystokinin (Cox et al., 1995) and orexin (Bayer et al., 2002) depolarize relay or thalamic reticular neurons via inhibition of leak K+ currents. In the rodent thalamus, a dense network of pituitary adenylate cyclase-activating polypeptide (PACAP)-containing fibers is present in central nuclei (Köves et al., 1991), whereas vasoactive intestinal polypeptide (VIP) mRNA is detected in both relay nuclei and part of the nucleus reticularis (Burgunder et al., 1999). The PACAP peptide contains 38 aa and shares 68% identity with VIP. Therefore, PACAP and VIP belong to the VIP–glucagon–growth hormone-releasing factor–secretin superfamily (Vaudry et al., 2000). Three classes of PACAP/VIP receptors have been cloned, namely PAC1 receptors, which have higher binding affinities for PACAP (<10 nm) than VIP, and VPAC1 and VPAC2receptors, which have equal binding affinities for PACAP and VIP (<10 nm). Abundant expression of PAC1receptors and lower levels of VPAC1 and VPAC2 receptors have been documented in most thalamic nuclei (Vaudry et al., 2000), suggesting broad effects on thalamocortical functions. However, the physiological roles of VIP/PACAP in thalamocortical activation are not clear. In the CNS and the peripheral nervous system, PAC1 receptors are known to stimulate cAMP formation (Vaudry et al., 2000), which in turn is known to have potent activating effects onIH channels (Ludwig et al., 1998;Lüthi and McCormick, 1998; Santoro and Tibbs, 1999; Wainger et al., 2001). PACAP and VIP modulate a variety of ion channels, such as N-type Ca2+ channels (Zhu and Yakel, 1997), small conductance Ca2+-activated K+channels (Haug and Storm, 2000) and sodium-dependent conductances (Kohlmeier and Reiner, 1999); however, their effects onIH channels have not been examined. Therefore, we tested the hypothesis that VIP and PACAP regulate the thalamocortical neuronal firing mode through actions onIH.
Materials and Methods
Slice preparation. All experiments were performed using a protocol approved by the Stanford Institutional Animal Care and Use Committee. Young Sprague Dawley rats [12–20 d of age; postnatal day 12 (P12)–P20] were deeply anesthetized with pentobarbital sodium (55 mg/kg) and decapitated. The brains were quickly removed and placed into cold (∼4°C) oxygenated slicing medium containing (in mm): 2.5 KCl, 1.25 NaH2PO4, 10 MgCl2, 0.5 CaCl2, 26 NaHCO3, 11 glucose, and 234 sucrose. Tissue slices (300–400 μm) were cut in the horizontal plane using a vibratome (TPI, St. Louis, MO), transferred to a holding chamber, and incubated (35°C) for at least 1 hr before recording. Individual slices were then transferred to a recording chamber fixed to a modified microscope stage and allowed to equilibrate for at least 30 min before recording. Slices were minimally submerged and continuously superfused with oxygenated physiological saline at 4.0 ml/min. Recordings were obtained at 35 ± 1°C. The physiological perfusion solution contained (in mm): 126 NaCl, 2.5 KCl, 1.25 NaH2PO4, 2 MgCl2, 2 CaCl2, 26 NaHCO3, and 10 glucose. All solutions were gassed with 95% O2–5% CO2 to a final pH of 7.4.
Whole-cell patch-clamp recording. Whole-cell recordings were obtained using visualized slice patch techniques (Edwards et al., 1989) and a modified microscope (Axioskop; Zeiss, Thornwood, NY) with a fixed stage. A low-power objective (2.5×) was used to identify the various thalamic nuclei, and a high-power water immersion objective (40×) with Nomarski optics and infrared video was used to visualize individual neurons.
Recording pipettes were fabricated from capillary glass (M1B150F-4;World Precision Instruments, Sarasota, FL), using a Sutter Instruments (Novato, CA) P80 puller, and had tip resistances of 2–5 MΩ when filled with the intracellular solutions below. An Axopatch1A amplifier (Axon Instruments, Foster City, CA) was used for voltage- and current-clamp recordings. Access resistance in whole-cell recordings ranged from 4 to 12 MΩ, was stable during the recording period, and was electronically compensated in voltage-clamp experiments by 50–75%. Current and voltage protocols were generated using pClamp software (Axon Instruments). The following software packages were used for data analysis: Clampfit (Axon Instruments), Winplot (courtesy of N. Dale, St. Andrews University, Fife, UK), and Origin (Microcal Software, Northampton, MA). The whole-cell patch pipette saline was composed of (in mm): 100 K-gluconate, 13 KCl, 9 MgCl2, 0.07 CaCl2, 10 EGTA, 10 HEPES, 2 Na2-ATP, and 0.4 Na-GTP. The pH was adjusted to 7.4, and the osmolarity was corrected to 280 mosm/l. This solution was also used as pipette saline for current-clamp recordings.
Drugs. Drugs were applied focally through a multibarrel microperfusion pipette that was positioned within 1 mm of the cell. VIP/PACAP analogs: concentrated VIP (Peninsula Laboratories, Belmont, CA) stock solutions were dissolved in ultrapure water to a final concentration of 0.2 mand stored in a −70°C freezer. Stock VIP solutions were diluted in physiological saline to final concentrations of 100 nm to 2 μm 1 hr before use. Unless otherwise noted, a concentration of 1 μm was used. Concentrated PACAP38 (Peninsula Laboratories) and [Ala11,22,28] VIP (Tocris, Ballwin, MO) solutions were also stored at −70°C. Aliquots were diluted to a final concentration in physiological solution just before use and applied via multibarrel focal perfusion. The following ion channel blockers and chemicals were used: bicuculline methiodide (Sigma, St. Louis, MO), TTX (Sigma), ZD7288 (Tocris), and 8-(4-chlorophenylthio)-cAMP (8-cpt-cAMP; Sigma).
Statistics. All data are presented as mean ± SEM unless otherwise stated. Analysis by Student's t test was performed for paired and unpaired observations unless otherwise stated.p values of <0.05 were considered statistically significant.
Results
VIP and PACAP reversibly depolarize thalamocortical neurons and change their firing mode
Whole-cell patch-clamp recordings were made predominantly from neurons located in the somatosensory region [ventrobasal (VB) complex] of the thalamus. In current-clamp mode, the average membrane resting potential recorded from thalamocortical neurons in vitro was −63 ± 1 mV (n = 16). The mean membrane input resistance, determined from the application of 1 sec hyperpolarizing current steps (−50 pA), was 188 ± 22 MΩ (n = 16). A series of constant-duration hyperpolarizing and depolarizing current pulses (±100 pA, 200 msec) were applied to the relay neurons every 10 sec, and the effects of exogenous VIP on the excitability of relay neurons were studied. Exposure of neurons to VIP (2 μm) elicited robust and at least partially reversible membrane depolarizations in 16 of 16 cells (Figs. 1A,2A,3A3, summary in Fig.2D). Local or bath application of VIP (2 μm) depolarized relay neurons by 7.8 ± 0.6 mV (n = 16; p < 0.001 vs controls) (Figs. 1A,2A,B,D,3A3).
The VIP-mediated depolarizations were long-lasting, normally requiring at least 20 min for washout (Figs. 1A,2A, 3A), and recovery was often incomplete (Figs. 2A, 3A3). The slow reversal of the VIP depolarization does not seem to be an artifact of whole-cell patch-clamp recordings, because under the same conditions in other experiments, G-protein-coupled NPY receptor-mediated hyperpolarizing responses were rapidly and completely reversible during an equivalent period (cf. Sun et al., 2001). The long-lasting effects mediated by VIP and PACAP suggest that perhaps a diffusible second messenger, with either longer-lasting effects on target ion channels or slower inactivation, was activated by VIP and PACAP.
The VIP-induced alterations in membrane potential were associated with changes in membrane resistance as measured by responses to current steps (after nulling the VIP-induced membrane depolarizations; see responses to hyperpolarizing current pulses in Figs.1C1,C3). The average maximum input resistance in VIP was 127 ± 8 MΩ (n = 16), which was 67 ± 3% (p < 0.01) of controls. Both depolarization and decreased membrane resistance persisted in the presence of TTX (1 μm) (Fig.1B). Under these conditions VIP (2 μm) produced comparable membrane potential depolarization (6.4 ± 1.2 mV in TTX; p > 0.5 vs VIP depolarizations in controls; n = 5) and alteration of membrane resistance (61 ± 7%; p > 0.5 vs VIP actions in controls). These results suggest that direct activation of postsynaptic VIP receptors on the recorded cells mediated PACAP/VIP effects on membrane potential in relay neurons.
Thalamocortical neurons exhibit tonic and burst firing modes (cf.Jahnsen and Llinas, 1984a,b; McCormick and Prince, 1987; Steriade and McCarley, 1990; McCormick and Bal, 1997). In relay neurons with relatively hyperpolarized resting membrane potentials (less than −63 mV; n = 8) (Fig. 1C), low-threshold burst discharges were reliably elicited by small depolarizing current steps (100–200 pA, 0.2 sec) (Figs. 1C, 2B1,3A1) (cf. Jahnsen and Llinas, 1984a,b). In seven of eight such hyperpolarized neurons, exposure to VIP caused robust depolarization and abolished directly evoked burst discharges (Figs.1C, 2B2 vs B1, 3A1,A2). In five of these eight neurons, burst discharge was replaced by tonic firing (Fig. 2B2 vsB1, 3A1,A2). The inhibitory effects of VIP on burst generation could be reversed by electronically nulling the effects on resting membrane potentials (Fig. 1C3 vsC2) (n = 7). PACAP38 (100 nm) mimicked the effects of VIP on resting membrane potential (7 ± 2 mV depolarization; n = 4; p < 0.05 vs controls) (Fig.2A,B), membrane conductance (134 ± 19 MΩ vs 178 ± 33 MΩ in controls;n = 4; p < 0.05), and firing mode (Fig. 2B4 vs B3). These effects of VIP and PACAP38 are similar to the previously described depolarizing effects of classical neurotransmitters, such as 5-HT, NA, and histamine, on relay neurons (Pape and McCormick, 1989; McCormick and Pape, 1990a,b;McCormick and Williamson, 1991). In cells with more depolarized membrane potentials (positive to −64 mV; n = 8; data not shown), VIP perfusion caused depolarization that resulted in a slightly increased tonic spontaneous firing rate (data not shown;n = 8). In summary, these results show that a common effect of VIP- and PACAP-mediated depolarization is to shift from burst mode to tonic firing mode.
Assessment of the morphologies of biocytin-filled cells, whose responses to VIP had been examined, revealed that thalamocortical neurons with different gross structures (Fig. 2C, cella–d) were depolarized to a similar extent. Cells located in widespread regions of the thalamus all responded to VIP (ventral posteromedial thalamic nuclei, seven neurons; ventral posterolateral and ventral lateral nuclei, six neurons; ventromedial thalamic nuclei, two neurons; posterior thalamic nuclei, five neurons). No notable differences in VIP sensitivity were detected among cells from these different anatomical locations. Therefore, VIP and PACAP modulation is present in a diverse group of thalamocortical neurons.
VIP activation of IH
Voltage-clamp recordings were made from thalamocortical neurons to determine the ionic mechanisms underlying the VIP-mediated depolarization of resting membrane potential. A series of hyperpolarizing voltage steps (1–2 sec) elicited large hyperpolarization-activated inward currents that showed a slow sigmoidal lag before reaching steady-state peak levels (data not shown). Activation could be fitted with a single exponential decay in 8 of 16 neurons. The time constant (τ) of activation showed voltage dependence and varied from 100 to 2000 msec at −130 to −80 mV (Figs. 4A1,A2, 5A3) (cf. McCormick and Pape, 1990; Munsch and Pape, 1999). The activation reached steady-state value during prolonged (>1 sec) hyperpolarizing steps (Figs. 3B1,4A1, 5A1,6A1). To determine the voltage dependence of IH activation, we measured the tail current amplitudes at a fixed membrane potential (−130 mV) (Fig. 4A1,Itail) (cf. Ludwig et al., 1998) after hyperpolarizing voltage steps to different test potentials. Activation curves were then fitted by a Boltzmann relationshipI/Imax = {1 + exp[(V +V1/2)/K]} to obtain the half-maximal activation (V1/2) and slope (K). In the majority of cells tested, the tail currents could be well fitted with a Boltzmann relationship (Fig.4A2,B1). The membrane potential at half-maximal activation was −88 ± 2.5 mV in VB relay neurons (Fig. 4B1) (n = 11), similar to that observed in relay neurons of mice (Santoro et al., 2000) and in other studies in rats (cf. Munsch and Pape, 1999).
The addition of VIP (1 μm) reversibly enhancedIH activation but had little effect on currents elicited at membrane potentials more positive than −50 mV (Figs. 3B3, 4B1). Additional analysis ofIH activation curves recorded in the presence of VIP revealed significant rightward shifts toward more depolarized potentials in half-activation potential (7.2 ± 1 mV;n = 11; p < 0.001 vs controls) (Fig.4B1,B2). This shift resulted in a significant increase in the currents activated between −60 and −70 mV (66 ± 4%; n = 11) (Fig.4B1,B4) (p< 0.001). However, it only resulted in a 30 ± 2% enhancement of currents elicited at −120 mV (Fig.4B1,B3) (n = 11;p < 0.001). The VIP-mediated enhancement ofIH was also accompanied by reversible acceleration of the activation time constant (Fig.5A1,A2). This shortening of activation time constant occurred in a voltage-dependent manner, with larger changes occurring at more depolarized test potentials (Fig. 5A3) (n = 5). At −100 mV, the activation time constant measured under control conditions varied from 500 to 750 msec with a mean value of 636 ± 20 msec (n = 8). Exposure of relay neurons to VIP significantly shortened the activation time constant in seven of eight cells, with a mean value of 481 ± 23 msec (n = 8;p < 0.01 vs controls and washout) (Fig.5B1,B2).
A specific inhibitor of IH, ZD7288 (50 μm) (BoSmith et al., 1993), was applied to determine whether additional ionic conductances might contribute to the VIP-mediated modulation of membrane properties in relay neurons. Constant hyperpolarizing voltage-clamp steps (−100 mV, 1 sec) (Fig.6B1) were applied to relay neurons at 0.1 Hz. Switching local perfusate from control saline to VIP-containing saline caused enhancement of the inward currents (Fig. 6A1). The addition of ZD7288 significantly reduced control hyperpolarization-activated currents from 989 ± 21 to 445 ± 20 pA (Fig. 6A1) (n = 8;p < 0.01 vs predrug). After the effects of ZD7288 reached a steady-state level, VIP was added to the local perfusate, and under these conditions VIP had no additional effect on currents evoked by voltage steps (446 ± 18 pA; p > 0.5 vs ZD7288; n = 6) (Fig.6A1,A2). In another occlusion experiment, voltage ramps (from −50 to −130 mV) were applied to thalamocortical neurons, and the effects of VIP on instantaneous currents were studied in the presence of the IH channel inhibitor ZD7288. In six such neurons tested, VIP had no significant effect on the currents elicited by voltage ramps (Fig.6B1,B2) (n = 6), suggesting that IH channels are the major targets of VIP modulation.
VIP- and PACAP-mediated effects on IHare mediated by PAC1 receptors and cAMP
To establish the pharmacological profile of the VIP-mediated effects on IH, various concentrations of VIP and selective VPAC and PAC1 receptor agonists were applied to relay neurons. We used voltage steps (−100 mV, 2 sec) to elicit IH, and the effects of 20 nm, 50 nm, 100 nm, 1 μm, and 2 μm VIP were studied. We found that the VIP-mediated response was present at concentrations of 200 nm (n = 5) (Fig.7A2) and was larger and probably maximal at 1 μm, because 2 μm VIP induced no additional activation ofIH (n = 6; data not shown). These results suggest that the VIP response is not likely to be mediated by VPAC receptors, which have a high affinity for VIP (<10 nm) (cf. Vaudry, 2000). Consistent with this, the effects of VIP on IH were not mimicked by the selective VPAC2 receptor agonist [Ala11,22,28] VIP (100 nm; n = 6; p > 0.5 vs controls) (Fig. 7C) but were reproduced by a low concentration of PACAP38, a broad spectrum agonist (10–100 nm) (Fig. 7B2 vsB1,B4,C) (p < 0.05; n = 6). The effects of PACAP38 onIH current had a biophysical profile similar to that of VIP, including a right shift of half-activation potential (6 ± 1 mV; n = 5) and acceleration of activation time constant (Fig. 7B3) (n = 6). In summary, these results suggest that PAC1receptors mediated the effects of VIP onIH in thalamocortical neurons.
Because the VIP and PAC1 receptors are known to induce elevation of intracellular cAMP via adenylyl cyclase, we subsequently tested whether exogenous application of membrane-permeable cAMP analogs would reproduce and/or occlude VIP effects. Exogenously applied 8-cpt-cAMP alone mimicked the effects of PACAP38 and VIP onIH in five of six neurons examined (Fig. 7B3 vs B2, B1,B4,C). Furthermore, the effects of 8-cpt-cAMP onIH were occluded by 1 μm VIP (Fig. 7C) (n= 6; p = 1 vs VIP alone in the same cells). These results suggest that VIP receptor activation, via elevation of intracellular cAMP levels, leads to activation ofIH channels in thalamocortical neurons.
Discussion
Regulation of HCN channels by classical and peptidergic neurotransmitters
IH channels are encoded by a family of genes, including HCN1, HCN2,HCN3, and HCN4. In rodent thalamic relay nuclei, abundant HCN2 andHCN4 mRNA were detected in mice (Moosmang et al., 1999; Santoro et al., 2000), but onlyHCN4 transcripts were found in rat relay nuclei (Monteggia et al., 2000). These HCN channels differ in their kinetics, steady-state voltage dependence, and the extent of modulation by cAMP (Wainger et al., 2001). For example, both HCN2 and HCN4 channels exhibit slow voltage- and time-dependent activation kinetics compared withHCN1 channels. However, in expression systems,HCN4 channels showed slower activation thanHCN2 channels, a less steep voltage dependence for activation, and less of a rightward shift of half-activation voltages by cAMP (Ludwig et al., 1999). In rat thalamocortical neurons, previous studies have characterized the properties ofIH and its modulation by neurotransmitter receptors (Pape and McCormick, 1989; McCormick and Pape, 1990a,b; for review, see Pape, 1996). The kinetics ofIH in our study is very similar to those described in these previous studies. For example, the half-activation membrane potential in our experiments was −88.5 ± 2.5 mV, similar to that reported previously (Munsch and Pape, 1999). The time-dependent activation of IHcould be fitted with a single exponential equation with a mean time constant that varied from 100 msec to 2 sec (cf. McCormick and Pape, 1990a; Munsch and Pape, 1999). In mouse thalamocortical neurons, however, currents elicited by hyperpolarizing steps decay with a biphasic time course, rather than exhibiting a single exponential decay (Santoro et al., 2000). These discrepancies betweenIH in mice versus rat relay neurons may be related to expression of different HCN genes (HCN2 and HCN4 in mice vs more HCN4 in rats).
Our results show that PACAP38 peptide in nanomolar concentrations and VIP in micromolar concentrations produce robust activation ofIH in relay neurons. These peptides caused a shift of half-activation voltages (+7 mV) toward more depolarized membrane potentials. These effects are quantitatively identical to the activation of IH by 5-HT and noradrenaline in thalamic neurons (+6 mV shifts ofV1/2) (cf. McCormick and Pape, 1990a,b). Interestingly, in thalamocortical relay neurons, a variety of neurotransmitters (Pape and McCormick, 1989; McCormick and Pape, 1990a,b) and direct application of cAMP (Lüthi and McCormick, 1998, 1999) cause quantitatively very similar shifts of half-activation voltages (approximately +7 mV) (for review, see Santoro and Tibbs, 1999). These data suggest that each of these neurotransmitters could elevate intracellular cAMP concentrations sufficiently to maximally shift IH activation.
Our data also indicate that the rightward shift of voltage-dependent activation by VIP had a strong effect onIH and could elicit 60% increases in relative activation at physiologically relevant membrane potentials (between −70 and −60 mV) (Figs. 4B1,5B). Therefore, low concentrations of endogenous PACAP peptides could potentially alter thalamocortical neuron firing modes (Figs. 1C, 3A). Because peptidergic actions tend to be slower in onset and longer lasting compared with classical neurotransmitters (Jan and Jan, 1981), the regulation ofIH channels by PACAP suggests an additional and novel pathway through which thalamocortical activity may be regulated.
To our knowledge, other than the results presented here, there is very little evidence for upregulation of IHby endogenous neuropeptides in the mammalian CNS. Results of several studies have shown the opposite effects of peptides, namely an inhibition of IH. For, example, opioids decrease IH and a potassium current in hippocampal interneurons (Svoboda and Lupica, 1998), substance P inhibits IH via neurokinin (NK1) receptors in vagal sensory neurons (Jafri and Weinreich, 1998), and neurotensin inhibitsIH in the rat substantia nigra pars compacta (Cathala and Paupardin-Tritsch, 1997). The ability of neuropeptides to decrease IH may be mediated by inhibition of adenylyl cyclase (Ingram and Williams, 1994) and activation of PKC pathways (cf. Cathala and Paupardin-Tritsch, 1997).
VIP/PACAP PAC1 receptor-mediated actions in thalamus and other parts of the brain
Despite the wide distribution of endogenous PACAP/VIP peptides in nerve terminals of the central and peripheral nervous systems, very little is known about the physiological roles of these peptides in the brain. Limited evidence suggests that these peptides can activate a range of G-protein-coupled receptors that then activate a number of downstream second messengers which, in turn, regulate neuronal excitability. For example, PACAP in nanomolar concentrations, via activation of PAC1 receptors, depolarizes rat sympathetic neurons by suppressing both potassium conductance and sodium influx. These effects are mediated by Gq proteins and activation of phospholipase C-dependent IP3pathways (Beaudet et al., 2000). Interestingly, also in rat sympathetic neurons, a high concentration of VIP (10 μm) produced cholera-toxin-sensitive voltage-dependent inhibition of N-type calcium channels (Zhu and Yakel, 1997). However, it is not known which receptors mediate this response. These two studies suggest that multiple neuropeptidergic receptors can coexist within a neuron and exert different physiological functions. In another very relevant study, VIP was shown to evoke excitatory actions in medial pontine reticular formation neurons that are implicated in the control of the sleep–wakefulness cycle. The effects of VIP on these neurons occurred at a low concentration (<100 nm) and were mediated by cAMP, protein kinase A, and sodium-dependent conductance (Kohlmeier and Reiner, 1999). In hippocampal pyramidal neurons, VIP modulates slow AHP currents (SK currents) by activation of adenylyl cyclase and cAMP (Haug and Storm, 2000).
Three PACAP family peptide receptors, belonging to the seven transmembrane receptor G-protein-coupled receptor superfamily, have been cloned to date. On the basis of pharmacological profiles, these receptors can be subgrouped into two classes: type I receptors, which include PAC1 receptors, and type II receptors, which include VPAC1 and VPAC2 receptors. Type I receptors show different binding affinities for VIP (>500 nm) and PACAP38 (0.5 nm), whereas type II receptors (VPAC1and VPAC2) show similar binding affinities for VIP (1 nm) and PACAP (1 nm). In virtually all thalamic nuclei, PAC1 receptors are highly expressed, whereas VPAC1 receptors are not expressed in the thalamus. Moderate levels of VPAC2 receptors have been detected in the thalamus, but their distribution is unclear (for review, see Vaudry et al., 2000). We found that the modulation ofIH by VIP was not maximal at concentrations of 200 nm. The selective VPAC2 receptor agonist [Ala11,22,28] VIP (100 nm) overall had no significant effects onIH modulation. Therefore, we conclude that the effects of VIP and PACAP38 onIH in thalamocortical neurons are predominantly mediated by PAC1 receptors. Our results provide the first example of activation ofIH channels by an endogenous neuropeptide in the thalamus, an action that may influence both normal and pathophysiological thalamocorticalrhythm generation and may have important resultant behavioral effects on the regulation of sensory processing and modulation of sleep–wake cycles.
Behavioral studies have shown that intracerebral injection of PACAP (Fang et al., 1995) or VIP (Bourgin et al., 1997) enhances REM sleep in several species, including rats. In humans, intravenous administration of VIP caused an increased duration of REM periods and an increase in the REM-to-non-REM ratio (Murck et al., 1996). However, the mechanisms underlying the PACAP/VIP-mediated behavioral effects are not entirely clear. Direct microinjection of PACAP or VIP into several brainstem regions, including the oral pontine reticular nucleus, results in long-term enhancement of REM sleep (Bourgin et al., 1997; Ahnaou et al., 2000). This is likely mediated in pontine reticular formation neurons in part by VIP receptors, cAMP, and a sodium conductance (Kohlmeiet and Reiner, 1999). Here, we show that in the thalamus, PACAP and VIP caused a robust depolarization of thalamocortical neurons that could result in transformation of firing mode from burst to tonic. The transition from sleep (non-REM) to waking or REM sleep is known to be associated with steady depolarization of thalamocortical neurons and thalamic reticular neurons (Hirsch et al., 1983; for review, seeSteriade and McCarley, 1990; McCormick and Bal, 1997). Therefore, we speculate that PACAP/VIP receptor activation in the thalamus may play a supportive role in the regulation of REM sleep.
Footnotes
This work was supported by National Institute of Neurological Disorders and Stroke Research Grant NS12151 and by the Pimley Research and Training Funds. We are grateful to Isabel Parada for excellent assistance in the immunocytochemistry experiments.
Correspondence should be addressed to John R. Huguenard at the above address. E-mail: John.Huguenard{at}stanford.edu.